258 related articles for article (PubMed ID: 21244707)
61. Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells.
Chang YW; Singh KP
PLoS One; 2017; 12(3):e0174227. PubMed ID: 28323900
[TBL] [Abstract][Full Text] [Related]
62. Ai-lncRNA EGOT enhancing autophagy sensitizes paclitaxel cytotoxicity via upregulation of ITPR1 expression by RNA-RNA and RNA-protein interactions in human cancer.
Xu S; Wang P; Zhang J; Wu H; Sui S; Zhang J; Wang Q; Qiao K; Yang W; Xu H; Pang D
Mol Cancer; 2019 Apr; 18(1):89. PubMed ID: 30999914
[TBL] [Abstract][Full Text] [Related]
63. Paclitaxel inhibits the progression of cervical cancer by inhibiting autophagy via lncRNARP11-381N20.2.
Zou SH; Du X; Lin H; Wang PC; Li M
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3010-3017. PubMed ID: 29863245
[TBL] [Abstract][Full Text] [Related]
64. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
65. Inhibitory effect of ARHI on pancreatic cancer cells and NF-κB activity.
Hu YQ; Si LJ; Ye ZS; Lin ZH; Zhou JP
Mol Med Rep; 2013 Apr; 7(4):1180-4. PubMed ID: 23447002
[TBL] [Abstract][Full Text] [Related]
66. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer.
Lu Z; Luo RZ; Peng H; Rosen DG; Atkinson EN; Warneke C; Huang M; Nishmoto A; Liu J; Liao WS; Yu Y; Bast RC
Clin Cancer Res; 2006 Apr; 12(8):2404-13. PubMed ID: 16638845
[TBL] [Abstract][Full Text] [Related]
67. The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms.
Lu Z; Bast RC
Cell Adh Migr; 2013; 7(2):232-6. PubMed ID: 23357870
[TBL] [Abstract][Full Text] [Related]
68. Distinct subgroup of the Ras family member 3 (DIRAS3) expression impairs metastasis and induces autophagy of gastric cancer cells in mice.
Qiu J; Li X; He Y; Sun D; Li W; Xin Y
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1869-1886. PubMed ID: 30043279
[TBL] [Abstract][Full Text] [Related]
69. Apogossypolone induces autophagy and apoptosis in breast cancer MCF-7 cells in vitro and in vivo.
Niu X; Li S; Wei F; Huang J; Wu G; Xu L; Xu D; Wang S
Breast Cancer; 2014 Mar; 21(2):223-30. PubMed ID: 22711315
[TBL] [Abstract][Full Text] [Related]
70. Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis.
Weber F; Aldred MA; Morrison CD; Plass C; Frilling A; Broelsch CE; Waite KA; Eng C
J Clin Endocrinol Metab; 2005 Feb; 90(2):1149-55. PubMed ID: 15546898
[TBL] [Abstract][Full Text] [Related]
71. Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells.
Liu Z; Marquez M; Nilsson S; Holmberg AR
Oncol Rep; 2008 Jul; 20(1):151-4. PubMed ID: 18575731
[TBL] [Abstract][Full Text] [Related]
72. WWOX promotes apoptosis and inhibits autophagy in paclitaxel‑treated ovarian carcinoma cells.
Zhao Y; Wang W; Pan W; Yu Y; Huang W; Gao J; Zhang Y; Zhang S
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300063
[TBL] [Abstract][Full Text] [Related]
73. Correlation of ARHI upregulation with growth suppression and STAT3 inactivation in resveratrol-treated ovarian cancer cells.
Zhong LX; Nie JH; Liu J; Lin LZ
Cancer Biomark; 2018; 21(4):787-795. PubMed ID: 29504523
[TBL] [Abstract][Full Text] [Related]
74. Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer.
Xiang S; Dauchy RT; Hoffman AE; Pointer D; Frasch T; Blask DE; Hill SM
J Pineal Res; 2019 Sep; 67(2):e12586. PubMed ID: 31077613
[TBL] [Abstract][Full Text] [Related]
75. [The synergistic inhibitory effect of 5-aza-2-deoxycytidine and Tamoxifen on estrogen receptor alpha negative breast cancer cell lines in vitro].
Tang B; Peng ZH; Jiang J
Zhonghua Wai Ke Za Zhi; 2005 Dec; 43(23):1545-9. PubMed ID: 16412295
[TBL] [Abstract][Full Text] [Related]
76. Suppression of autophagy enhances preferential toxicity of paclitaxel to folliculin-deficient renal cancer cells.
Zhang Q; Si S; Schoen S; Chen J; Jin XB; Wu G
J Exp Clin Cancer Res; 2013 Dec; 32(1):99. PubMed ID: 24305604
[TBL] [Abstract][Full Text] [Related]
77. [Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer].
Tang X; Lu M; Li C; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):517-22. PubMed ID: 25327734
[TBL] [Abstract][Full Text] [Related]
78. [Overexpression of aplysia Ras homolog I (ARHI) increases apoptosis in colon cancer SW480 cells].
Chen X; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Nov; 32(11):1503-1506. PubMed ID: 27774944
[TBL] [Abstract][Full Text] [Related]
79. [Synergistic cytotoxicity effect of histone deacetylase inhibitor combined with paclitaxel on lung cancer cell lines and its mechanism].
Zhang D; Liu CT; Yu XD; Liu Y
Ai Zheng; 2009 Dec; 28(12):1270-6. PubMed ID: 19958621
[TBL] [Abstract][Full Text] [Related]
80. Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells.
Xi G; Hu X; Wu B; Jiang H; Young CY; Pang Y; Yuan H
Cancer Lett; 2011 Aug; 307(2):141-8. PubMed ID: 21511395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]